Europe and Northern America vs Laos: Percentage of bloodstream infection due to Escherichia coli resistant

Europe and Northern America
11.6%
in 2022
Laos
52.6%
in 2022
Europe and Northern America rank
15th
Laos rank
17th

Percentage of bloodstream infection due to Escherichia coli resistant over time

  • Europe and Northern America
  • Laos
1020304050201620192022

How they compare

Laos currently reports 52.6% against 11.6% in Europe and Northern America, a difference of 41.0%.

That makes Laos's figure about 4.5 times Europe and Northern America's.

Across all 6 years both countries report, Laos has been ahead every year.

Europe and Northern America ranks 15th and Laos ranks 17th of 16 groups.

Laos has averaged higher in every one of the 2 decades both report.

Head to head by decade

Decade Europe and Northern America Laos Difference Ahead
2010s 23.3% 46.9% 23.6% Laos
2020s 11.5% 49.7% 38.2% Laos

Averages of every year both report within each decade.

Frequently asked questions

Which has higher percentage of bloodstream infection due to escherichia coli resistant, Europe and Northern America or Laos?
Laos, at 52.6% against 11.6% in Europe and Northern America as of 2022.
What is the difference in percentage of bloodstream infection due to escherichia coli resistant between Europe and Northern America and Laos?
41.0%, with Laos ahead.
How many years of comparable data are there for Europe and Northern America and Laos?
6 years are reported by both, from 2017 to 2022.
How do Europe and Northern America and Laos rank globally for percentage of bloodstream infection due to escherichia coli resistant?
Europe and Northern America ranks 15th and Laos ranks 17th of 16 groups.
Where does this data come from?
United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

Europe and Northern America vs Laos: Percentage of bloodstream infection due to Escherichia coli resistant. Statizoid, drawing on United Nations Statistics Division, SDG Global Database. Retrieved 17 September 2026, from https://development-goals.statizoid.com/compare/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/europe-and-northern-america/lao-pdr/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under UN SDG Global Database (open, attribution requested); please keep the attribution.

<a href="https://development-goals.statizoid.com/compare/percentage-of-bloodstream-infection-due-to-escherichia-coli-resistant-to-3rd-generation/europe-and-northern-america/lao-pdr/">Europe and Northern America vs Laos: Percentage of bloodstream infection due to Escherichia coli resistant</a> — Statizoid

About this data

Indicator
Percentage of bloodstream infection due to Escherichia coli resistant to 3rd-generation cephalosporin (e.g., ESBL- E. coli) among patients seeking care and whose blood sample is taken and tested (%)
Source
United Nations Statistics Division, SDG Global Database
Licence
UN SDG Global Database (open, attribution requested)
Coverage
66 places, 407 data points, 2016–2022
Last refreshed